These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37616477)

  • 1. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of time to clozapine prescription on the clinical outcome.
    Muñoz-Manchado LI; Perez-Revuelta JI; Banerjee A; Galindo-Guarin L; Bernardo M; González-Saiz F; Villagrán-Moreno JM; Fernández-Egea E
    Schizophr Res; 2024 Jun; 268():189-192. PubMed ID: 37805277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
    Taylor DM; Young C; Paton C
    J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine use in early psychosis.
    Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B
    Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia.
    Üçok A; Çikrikçili U; Karabulut S; Salaj A; Öztürk M; Tabak Ö; Durak R
    Int Clin Psychopharmacol; 2015 Sep; 30(5):290-5. PubMed ID: 26163875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
    Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE;
    Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of clozapine prescribing in a mental health service in New Zealand.
    Harrison J; Janlöv M; Wheeler AJ
    Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating Predictors of Clozapine Response in Adolescents with Schizophrenia and Schizoaffective Disorder.
    Karacetin G; Ermis C; Bulanik Koc E; Saglam Y
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):504-510. PubMed ID: 34283936
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
    Yoshimura B; Sakamoto S; Sato K; Takaki M; Yamada N
    Early Interv Psychiatry; 2019 Jun; 13(3):589-597. PubMed ID: 29498481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices.
    Grimminck R; Oluboka O; Sihota M; Rutherford DL; Yeung H
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32678523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.